Skip to content

RXRXRECURSION PHARMACEUTICALS-A

CUSIP 75629V104 · common stock

2 tracked investors held RECURSION PHARMACEUTICALS-A (RXRX) at the end of Q3 2026, worth $185M in total. The largest holder was Cathie Wood, with 1.1% of its portfolio.

Holders · Q3 2026
2
New holders
0
Value held
$185M
Quarter-end price (est.)
$4.13

Investors holding RXRX · Q3 2026

InvestorWeightSharesValueChange
Cathie Wood
ARK Investment Management LLC
1.06%44,745,025$184.8MADD+8.2%
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.01%56,000$231.3KADD+36.6%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026200$185M$4.13
Q2 2026200$151.9M$3.67
Q1 2026200$123.6M$3.07
Q4 2025200$152.8M$4.09